Search - tctmd.com

Displaying 281 - 300 of 484

Sort: Relevancy | Date

Presentation TCT 2016

Neoatherosclerosis as A Cause of Very Late DES Failure: Insights From Multimodality Imaging Studies

Presenter: Fernando Alfonso, Stephan Windecker, Yasunori Ueda

October 30, 2016

Presentation TCT 2016

Can Improvements in Metallurgy and Stent Design Improve Early and Late Outcomes With DES?

Presenter: Fernando Alfonso, Stephan Windecker, Elazer R. Edelman

October 30, 2016

Presentation TCT 2016

Mechanisms of Late and Very Late Restenosis: Is Improved Technology the Answer?

Presenter: Fernando Alfonso, Stephan Windecker, Juan F. Granada

October 30, 2016

Presentation TCT 2016

Pathologic Insights Into Vascular Healing and the Causes of Stent Thrombosis and Restenosis: Are We Making Progress as Stents Evolve?

Presenter: Fernando Alfonso, Stephan Windecker, Aloke V. Finn

October 30, 2016

Presentation TCT 2016

Very Late Failures After Metallic DES: Frequency and Clinical Predictors

Presenter: Fernando Alfonso, Stephan Windecker, Mahesh V Madhavan

October 30, 2016

Presentation TCT 2016

Restenosis and Stent Thrombosis: Frequency, Predictors, and Treatments

Presenter: George D. Dangas, Rajesh V Swaminathan

October 30, 2016

Presentation TCT 2016

Lysis of Deep Venous Thrombosis

Presenter: Brian G. DeRubertis, Akhilesh K. Sista

October 30, 2016

Presentation TCT 2016

Case #3: Leaflet Thrombosis Following Transcatheter Valve-in-Valve: Could It Have Been Prevented?

Presenter: Stanley J. Chetcuti, Susheel K. Kodali, Isaac George

October 30, 2016

Presentation ESC 2016

ANTARCTIC: Assessment of a Normal vs Tailored Dose of Prasugrel After Stenting in 75 yo Patients to Reduce the Composite of Bleeding, Stent Thrombosis and Ischemic Complications

Presenter: Gilles Montalescot

August 28, 2016

Presentation

Prolonged High-Dose Bivalirudin Infusion Reduces Major Bleeding Without Increasing Stent Thrombosis in Patients Undergoing Primary PCI

Presenter: Gregor Fahrni

July 27, 2016

Presentation

Effect of Post-PPCI Bivalirudin Infusion on Acute Stent Thrombosis: Meta-analysis of RCTs

Presenter: Rahman Shah

June 20, 2016

Presentation TVT 2016

An Update on Subclinical Bioprosthetic Leaflet Thickening and Thrombosis: Possible Effects on TAVR Durability

Presenter: Raj Makkar

June 17, 2016

Presentation TVT 2016

The Incidence, Diagnosis, Impact, and Treatment of Valve Thrombosis After TAVR

Presenter: Azeem Latib

June 17, 2016

Presentation CCVVC 2016

Timing of DAPT Interruption and DES Thrombosis

Presenter: Usman Baber

June 16, 2016

Presentation CCVVC 2016

Subclinical Leaflet Thrombosis Post-TAVR

Presenter: Gian Paolo Ussia

June 16, 2016

Presentation TVT 2016

TVT 1127: Persistent Transcathter Valve Thrombosis Despite Full Anticoagulation

Presenter: Leo Marcoff, MD

June 16, 2016

Presentation TVT 2016

The Natural History of Leaflet Thrombosis and Abnormal Motion in Aortic Bioprosthetic Valves

Presenter: Lars Sondergaard

June 16, 2016

Presentation

Stent Thrombosis With DES and Absorb Bioresorbable Scaffold

Presenter: S.H. Kang

June 03, 2016

Presentation EuroPCR 2016

Effect of DAPT Termination at 12 Months on Very Late scaffold thrombosis in regular clinical practice: Data of a regional collaboration

Presenter: Robert-Jan van Geuns

May 18, 2016

Presentation Fellows 2016

Stent Thrombosis and Restenosis

Presenter: William A. Gray, Ajay J. Kirtane

April 16, 2016

Advertisement

Neoatherosclerosis as A Cause of Very Late DES Failure: Insights From Multimodality Imaging Studies

Can Improvements in Metallurgy and Stent Design Improve Early and Late Outcomes With DES?

Mechanisms of Late and Very Late Restenosis: Is Improved Technology the Answer?

Pathologic Insights Into Vascular Healing and the Causes of Stent Thrombosis and Restenosis: Are We Making Progress as Stents Evolve?

Very Late Failures After Metallic DES: Frequency and Clinical Predictors

Restenosis and Stent Thrombosis: Frequency, Predictors, and Treatments

Lysis of Deep Venous Thrombosis

Case #3: Leaflet Thrombosis Following Transcatheter Valve-in-Valve: Could It Have Been Prevented?

ANTARCTIC: Assessment of a Normal vs Tailored Dose of Prasugrel After Stenting in 75 yo Patients to Reduce the Composite of Bleeding, Stent Thrombosis and Ischemic Complications

Prolonged High-Dose Bivalirudin Infusion Reduces Major Bleeding Without Increasing Stent Thrombosis in Patients Undergoing Primary PCI

Effect of Post-PPCI Bivalirudin Infusion on Acute Stent Thrombosis: Meta-analysis of RCTs

An Update on Subclinical Bioprosthetic Leaflet Thickening and Thrombosis: Possible Effects on TAVR Durability

The Incidence, Diagnosis, Impact, and Treatment of Valve Thrombosis After TAVR

Timing of DAPT Interruption and DES Thrombosis

Subclinical Leaflet Thrombosis Post-TAVR

TVT 1127: Persistent Transcathter Valve Thrombosis Despite Full Anticoagulation

The Natural History of Leaflet Thrombosis and Abnormal Motion in Aortic Bioprosthetic Valves

Stent Thrombosis With DES and Absorb Bioresorbable Scaffold

Effect of DAPT Termination at 12 Months on Very Late scaffold thrombosis in regular clinical practice: Data of a regional collaboration

Stent Thrombosis and Restenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content